ERK kinase inhibition stabilizes the aryl hydrocarbon receptor: implications for transcriptional activation and protein degradation. [electronic resource]
- The Journal of biological chemistry Feb 2005
- 4350-9 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0021-9258
10.1074/jbc.M411554200 doi
Aminoacetonitrile--analogs & derivatives Apoptosis Blotting, Western Butadienes--pharmacology Cell Line Cell Line, Tumor Cell Nucleus--metabolism Centrifugation, Density Gradient Cytochrome P-450 CYP1A1--metabolism DNA Fragmentation Dose-Response Relationship, Drug Enzyme Inhibitors--pharmacology Extracellular Signal-Regulated MAP Kinases--antagonists & inhibitors Flavonoids--pharmacology Humans Immunoprecipitation Ligands Luciferases--metabolism MAP Kinase Kinase 1--metabolism Models, Chemical Nitriles--pharmacology Phosphorylation Plasmids--metabolism Polychlorinated Dibenzodioxins--chemistry Polymerase Chain Reaction Protease Inhibitors--pharmacology Protein Binding Protein Structure, Tertiary Proteins--metabolism RNA--metabolism Receptors, Aryl Hydrocarbon--chemistry Signal Transduction Sucrose--pharmacology Time Factors Transcription, Genetic Transcriptional Activation Transfection Ubiquitin--metabolism